Bone Biologics Co. (NASDAQ:BBLG) Sees Significant Decline in Short Interest

Bone Biologics Co. (NASDAQ:BBLG – Get Free Report) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 18,300 shares, a decline of 7.1% from the April 30th total of 19,700 shares. Based on an average daily volume of 104,300 shares, […]

Leave a Reply

Your email address will not be published.

Previous post Biora Therapeutics, Inc. (NASDAQ:BIOR) Sees Large Decline in Short Interest
Next post Bristol Gate Capital Partners Inc. Has $96.20 Million Stock Position in Moody’s Co. (NYSE:MCO)